Doxorubicin: Role in the treatment of osteosarcoma

This publication has 25 references indexed in Scilit:

• Antitumor Activity of Liposome-Encapsulated Doxorubicin in Advanced Breast Cancer: Phase II Study
  JNCI Journal of the National Cancer Institute, 1990
• Adriamycin and cis-platinum administered by continuous infusion preoperatively in hepatoblastoma unresectable at presentation
  Medical and Pediatric Oncology, 1990
• Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study
  European Journal of Cancer and Clinical Oncology, 1989
• Unknotting the Complexities of Multidrug Resistance: The Involvement of DNA Topoisomerases in Drug Action and Resistance
  JNCI Journal of the National Cancer Institute, 1989
• Keynote address: Glutathione modulation in cancer treatment: Will it work?
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Doxorubicin: Effect of different schedules on toxicity and anti-tumor efficacy
  European Journal of Cancer and Clinical Oncology, 1989
• Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26
  Biochemistry, 1988
• DNA Cross-linking and Cytotoxicity of the Alkylating Cyanomorpholino Derivative of Doxorubicin in Multidrug-Resistant Cells2
  JNCI Journal of the National Cancer Institute, 1988
• Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast Cancer
  New England Journal of Medicine, 1988
• The Role of Methotrexate in Osteosarcoma
  JNCI Journal of the National Cancer Institute, 1988